The effects COVID-19 has had on healthcare have been a significant part of nearly every article written here since March. The last time we looked into the costs associated with coronavirus infections, things were very different. We didn’t know what the summer would look like or how schools would reopen. Daily briefings from the White House were still happening.
The first U.S. case of COVID-19 was discovered in late January. By the end of February, there were 24 cases and one American death. In the first few weeks of the outbreak testing was very limited, sometimes as few as 300 for an entire state. It then took time for health officials to realize that the tests they received were flawed, lacking critical components, and delivering faulty results.
In late February, a Seattle team researching the flu found they could test for the SARS-CoV-2 coronavirus that causes COVID-19, but were running into bureaucratic red tape. When the doctors